Evaluation of Pathologic Complete Response (pCR) to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients with Estrogen Receptor Positive and HER2 Negative and impact of predicting variables on pCR

OBJECTIVE: The pathologic complete response (pCR) in the breast and axillary lymph node after neoadjuvant chemotherapy (NAC) would improve outcomes and it is used as a surrogate marker for survival. Our objective was to evaluate the breast and nodal pCR in breast cancer patients with estrogen recept...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Breast Health
Autores principales: Omranipour, Ramesh, Jalili, Roghiyeh, Yazdankhahkenary, Adel, Assarian, Abdolali, Mirzania, Mehrzad, Eslami, Bita
Formato: Artigo
Lenguaje:Inglês
Publicado: Turkish Federation of Breast Diseases Associations 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7337920/
https://ncbi.nlm.nih.gov/pubmed/32656523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/ejbh.2020.5487
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares